HEFT Repository

Evaluation of ThoraQuik: a new device for the treatment of pneumothorax and pleural effusion

Rathinam, Sridhar and Quinn, David W and Bleetman, Antony and Wall, Pete and Steyn, Richard S (2011) Evaluation of ThoraQuik: a new device for the treatment of pneumothorax and pleural effusion. Emergency medicine journal : EMJ, 28 (9). pp. 750-3. ISSN 1472-0213. This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their HEFT Athens login Ids

Full text not available from this repository.
Official URL: http://emj.bmj.com/content/28/9/750.abstract

Abstract

BACKGROUND

ThoraQuik is a device with a unique design incorporating an aspiration port and one-way valve controlled by a three-way tap, fit for purpose for the treatment of pneumothorax and pleural effusion. Its use, safety and efficacy were evaluated in a prospective observational trial.

METHODS

Stage 1: The safety and ability of the device to penetrate the chest wall and the ease of use were evaluated in patients undergoing thoracoscopic procedures by introducing the device at a second port site under vision. Stage 2: The device was evaluated on patients with pneumothorax and pleural effusion. Clinical and radiological improvement were endpoints and operator feedback was evaluated.

RESULTS

Phase 1: 10 patients (mean age: 48.5 years (18-76 years) six men) were studied between May 2005 and March 2007. Satisfactory penetration of the chest wall and safe entry in the pleural space was achieved. Phase 2: 20 patients (mean age: 59 years (24-81 years) 13 men) were recruited between May 2007 and May 2008. 10 patients presented with pneumothorax (tension pneumothorax, n=1) and 10 had pleural effusions. One patient withdrew consent and another patient was withdrawn as there was no fluid on trial aspiration. Of the 18 who completed the study, 10/18 had partial and 7/18 patients had complete resolution with no change in one. The qualitative assessments of the ThoraQuik in terms of ease of use and utility were positive.

CONCLUSIONS

ThoraQuik achieves satisfactory penetration of the chest wall. It was safe and easy to use to manage pneumothoraces and pleural effusions.

Item Type: Article
Additional Information: This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their HEFT Athens login Ids
Subjects: WF Respiratory system. Respiratory medicine
Divisions: Planned IP Care > Thoracic Surgery
Related URLs:
Depositing User: Mr Philip O'Reilly
Date Deposited: 04 Jul 2014 10:02
Last Modified: 04 Jul 2014 10:02
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/395

Actions (login required)

View Item View Item